Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial.
暂无分享,去创建一个
A. Shields | H. Kantarjian | S. Verstovsek | M. Deininger | R. Mesa | M. Talpaz | R. Silver | Carole B. Miller | J. Gotlib | Vikas Gupta | R. Levy | J. Catalano | E. Winton | T. Hare | J. Harvey | S. Erickson-Viitanen | William Sun | V. Sandor | S. Erickson‐Viitanen